In cancer, particularly TNBC—a subtype characterized by metabolic rewiring and defective apoptosis—aberrant expression of mitochondrial regulators such as HCCS may create a permissive environment for tumor progression and therapy resistance [22]. Here, HCCS is linked to neoplasm.